SEC Form D · Amendment · filed October 7, 2014
PROTEOSTASIS THERAPEUTICS, INC
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (25)
Christopher J. Mirabelli · CAMBRIDGE, MADirectorStephen J. Knight · CAMBRIDGE, MADirectorJanet J. Smart · CAMBRIDGE, MAExecBernard J. Davitian · CAMBRIDGE, MADirectorJeffery J. Kelly · CAMBRIDGE, MADirectorMeenu J. Chhabra · CAMBRIDGE, MAExecChristopher J. Walsh · CAMBRIDGE, MADirectorWalter Newman · CAMBRIDGE, MAExecMarkus Haeberlein · CAMBRIDGE, MAExecMichael Casey · CAMBRIDGE, MAExecLauren Silverman · CAMBRIDGE, MADirectorPeter Pau · Menlo Park, CADirectorThomas Arnold · Wilmington, DEDirectorJohn L. Atkins, Iii · Pasadena, CAExecThomas J. Andrews · Pasadena, CADirectorPeter M. Moglia · Pasadena, CAExec · DirectorJames H. Richardson · Pasadena, CAExec · DirectorDean A. Shigenaga · Pasadena, CADirectorJoel S. Marcus · Pasadena, CAExecDaniel J. Ryan · Pasadena, CAExec · DirectorRichard B. Jennings · Pasadena, CAExec · DirectorStephen A. Richardson · Pasadena, CAExec · DirectorRichard H. Klein · Pasadena, CAExecMaria C. Freire, Ph.D · Pasadena, CAExecSteven R. Hash · Pasadena, CADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗